SELLAS Life Sciences Group, Inc. (40) | License Agreements (3)
Recent Contracts
-
License Agreement effective as of March 31, 2022 by and between SELLAS Life Sciences Group, Inc. and GenFleet Therapeutics (Shanghai) Inc
(Filed With SEC on May 12, 2022)
-
Exclusive License Agreement by and among SELLAS, SLSG, and 3DMed, dated as of December 7, 2020
(Filed With SEC on January 28, 2021)
-
First Amendment to Amended and Restated Exclusive License Agreement between SLSG Limited LLC and Memorial Sloan Kettering Cancer Center, effective as of September 29, 2020
(Filed With SEC on November 13, 2020)
